An overview of the PI3K/PTEN/AKT pathway in cancer and efforts to understand its components and regulation will be presented. Efforts to use the pathway for cancer treatment will be discussed. Data from recent published and unpublished work from the Parsons lab focusing on AKT and PTEN-L will be shown and future directions summarized.
Dates and Times
Start: 11/4/2021 1:00 PM
End: 11/4/2021 2:00 PM
- Discuss the molecular features of the signaling pathway and how it regulates tumor development and growth
- Review of the different types of cancer with mutations of the pathway
- Overview of targeted therapies for the pathway for cancer
Level 5, MART
Stony Brook University, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.